HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Allergy & Immunology17 papers

Malignant neoplasm of middle ear

Last edited: 4/15/2026

Overview

Malignant neoplasm of the middle ear is a rare and aggressive tumor characterized by its origin from middle ear epithelium, displaying varied architectural patterns despite uniform cytological features 1.

Diagnosis

  • Histological Features: Uniform, round or ovoid cells resembling normal middle ear epithelium; architectural patterns include broad sheets, glandular, cribriform, and trabecular arrangements 1.
  • Immunohistochemistry: Positive for lysozyme, which can serve as a useful marker 1.
  • Special Stains: Grimelius argyrophil stains may show focal positivity, while Churukian-Schenk preparations typically show rare positive cells 1.

    • Management

  • Surgical Excision: Primary treatment, often curative with low recurrence rates 1.
  • Adjuvant Therapy: No specific adjuvant therapies mentioned; focus on complete surgical removal 1.

    • Special Populations

  • Recurrence and Prognosis: No specific data on pregnancy, pediatrics, or elderly populations; overall, tumors seldom recur post-excision and rarely invade bone, with no reported deaths from disease 1.

    • Key Recommendations

  • Surgical Excision as Primary Treatment: Ensure complete removal to minimize recurrence risks (Evidence: Moderate 1).
  • Monitoring Post-Excision: Regular follow-up is essential due to potential late recurrences despite low risk (Evidence: Expert opinion 1).
  • Immunohistochemical Markers: Utilize lysozyme staining to aid in diagnosis and confirm tumor origin from middle ear epithelium (Evidence: Moderate 1).

    • References

    1 Mills SE, Fechner RE. Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns. The American journal of surgical pathology 1984. link

    Original source

    1. [1]
      Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns. — Mills SE, Fechner RE The American journal of surgical pathology (1984)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG